What Does Approachable Automation Mean for Drug Safety Platforms?
There’s no doubt that the pharmaceutical industry is well into ...
Virtual Presentations, Real Results – “Leveraging Automation in PV” Presented at DIA 2020 Annual Meeting
Organizations currently utilizing manual pharmacovigilance processing understand that it involves many time-consuming manual activities, but ArisGlobal’s LifeSphere Multivigilance 10 is the future of pharmacovigilance.
Vaccine Safety in the Public Eye: How COVID-19 Brought Pharmacovigilance Center-Stage
The coronavirus pandemic ushered in a new era of public ...
Unlocking the Next Generation of Reporting and Analytics for Drug Safety Intelligence
The Future of Drug Safety Intelligence The future of safety ...
Turnkey Configuration and Next Level Standardization: ArisGlobal Works with Industry Leaders to Optimize Out-of-the-Box Safety Workflow
As part of our commitment to providing the most robust ...
Think Global, Watch Local: The DIA 2020 Annual Meeting Is Now Virtual, and ArisGlobal Is All In
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
The Role of ‘e- enablement’ Technology: Bridging the Gaps in Pharmacovigilance
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
The Silent Hero: How Advances in Today’s Technology Can Prevent, Assess, Detect, Treat and Predict Health Issues
Advanced computing methods can be used for safety monitoring and early detection of potential signals of vaccine-related adverse events. These methods work by mining open-access active-moiety databases and vast scientific literature with clinical case studies.
The Future of Pharmacovigilance Analytics and Insight
What will the next generation of reporting and analytics in ...
Taking a Best Practices Approach to Safety Signal Detection and Risk Management
Life sciences companies confront increasingly stringent requirements on safety signal detection and risk management. Regulatory authorities are taking steps to further safeguard patients by requiring companies to take more comprehensive steps to assess and monitor the benefit-risk balance of their products.
